eticlopride has been researched along with butaclamol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demattos, S; MacKenzie, RG; O'Malley, KL; Pugsley, TA; Shih, YH; Tang, L; Todd, RD; VanLeeuwen, D | 1 |
| Heller, A; O'Malley, KL; Tang, L; Todd, RD | 1 |
| Billings, J; Kung, HF; Kung, MP; Murphy, RA | 1 |
| Guo, YZ; Kasliwal, R; Kung, HF; Kung, MP; Mach, RH; Pan, SG | 1 |
| Billings, J; Chumpradit, S; Kung, HF; Kung, MP; Mach, R | 1 |
| Chen, J; Jiang, C; Keck, TM; Levant, B; Newman, AH; Wang, S | 1 |
| Senogles, SE | 1 |
7 other study(ies) available for eticlopride and butaclamol
| Article | Year |
|---|---|
Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
Topics: Animals; Arachidonic Acid; Binding, Competitive; Cell Line; CHO Cells; Cloning, Molecular; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Inositol Phosphates; Mice; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes; Transfection | 1994 |
Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines.
Topics: Adenylyl Cyclase Inhibitors; Animals; Base Sequence; Cells, Cultured; DNA Primers; Dopamine; Fibroblasts; GTP-Binding Proteins; Inositol Phosphates; Mice; Molecular Sequence Data; Neurons; Receptors, Dopamine; Transfection; Tumor Cells, Cultured | 1994 |
Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents.
Topics: Animals; Benzofurans; Binding, Competitive; Chemical Phenomena; Chemistry; Corpus Striatum; Iodine Radioisotopes; Isotope Labeling; Male; Molecular Structure; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Tissue Distribution | 1990 |
Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
Topics: Animals; Benzamides; Chemical Phenomena; Chemistry; Corpus Striatum; In Vitro Techniques; Iodine Radioisotopes; Male; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 1988 |
Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
Topics: Animals; Benzamides; Dopamine Agents; Dopamine D2 Receptor Antagonists; Fluorine Radioisotopes; Iodine Radioisotopes; Macaca fascicularis; Male; Pyrrolidines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1993 |
Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D₃ receptor antagonists.
Topics: Animals; Arrestins; beta-Arrestins; Cell Line; Cyclobutanes; Humans; Male; Naphthalenes; Radioligand Assay; Rats, Sprague-Dawley; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship; Tranylcypromine | 2014 |
The D2 dopamine receptor mediates inhibition of growth in GH4ZR7 cells: involvement of protein kinase-C epsilon.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Alprenolol; Animals; Apomorphine; Benzazepines; Butaclamol; Carcinogens; Cell Division; Cell Line; DNA; Dopamine; Ergolines; Humans; Isoenzymes; Kinetics; Norepinephrine; Pertussis Toxin; Phorbol Esters; Pituitary Neoplasms; Protein Kinase C; Quinpirole; Receptors, Dopamine D2; Salicylamides; Spiperone; Thymidine; Transfection; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1994 |